NHI:NYE-National Health Investors Inc.

EQUITY | REITs | New York Stock Exchange

Last Closing

USD 78.99

Change

0.00 (0.00)%

Market Cap

USD 2.83B

Volume

0.12M

Analyst Target

USD 78.25
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

National Health Investors Inc is a real estate investment trust. The Company is engaged in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing & medical investments.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-01-20 )

Largest Industry Peers for REITs

ETFs Containing NHI

DIV Global X SuperDividend U... 2.24 % 0.46 %

+0.08 (+0.47%)

USD 0.61B

Market Performance

  Market Performance vs. Industry/Classification (REITs) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.57% 38% F 34% F
Dividend Return N/A N/A N/A N/A F
Total Return 4.57% 38% F 34% F
Trailing 12 Months  
Capital Gain 13.17% 91% A- 92% A
Dividend Return 5.73% 44% F 78% C+
Total Return 18.90% 92% A 93% A
Trailing 5 Years  
Capital Gain 31.69% 74% C 76% C+
Dividend Return 29.81% 43% F 80% B-
Total Return 61.50% 71% C- 82% B
Average Annual (5 Year Horizon)  
Capital Gain 4.50% 79% B- 64% D
Dividend Return 9.72% 78% C+ 72% C
Total Return 5.23% 59% D- 78% C+
Risk Return Profile  
Volatility (Standard Deviation) 13.58% 41% F 54% F
Risk Adjusted Return 71.62% 63% D 71% C-
Market Capitalization 2.83B 67% D+ 73% C

Key Financial Ratios

  Ratio vs. Industry/Classification (REITs) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 16.40 44% 29%
Price/Book Ratio 2.45 26% 31%
Price / Cash Flow Ratio 3.99 37% 31%
Price/Free Cash Flow Ratio 15.96 36% 37%
Management Effectiveness  
Return on Equity 11.69% 76% 63%
Return on Invested Capital 8.17% 89% 48%
Return on Assets 6.01% 87% 73%
Debt to Equity Ratio 88.50% 59% 42%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector